Leadership Changes - Jay Jennings has been appointed as the Acting Chief Executive Officer of UpHealth, replacing Martin Beck, who resigned effective July 10, 2024 [5][8] - Lisa Fluxman has been promoted to President of TTC Healthcare, Inc., while Jeremy Livianu continues as Chief Legal Officer and Secretary of UpHealth [2][8] Company Overview - UpHealth, Inc. is a leading provider of a full continuum of behavioral health solutions, utilizing evidence-based treatments and services [3] - The company targets mental health issues and substance use disorders, offering various levels of care including detox, residential, partial hospitalization, intensive outpatient, outpatient, and telehealth [3] Board Statements - The Board expressed gratitude to Martin Beck for his service and confidence in the new leadership team to navigate ongoing restructuring and legal challenges [8]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-38924 UpHealth, Inc. (Exact name of registrant as specified in its charter) Delaware 83-3838045 (State ...

Ruling Reinforces $110 Million ICC Award in favor of UpHealth, UpHealth Reviews Affidavits to Develop Next Steps Forward-Looking Statements This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding the enforcement of the ICA's Final Award and the amounts to be paid to Holdings by the Respondents pursuant to the ICA's Final Award, control of Glocal and its operation, the proj ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-04321 UpHealth, Inc. (Exact name of registrant as specified in its charter) Delaware 83-3838045 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 (State or ot ...

Exhibit 99.1 UPHEALTH PROVIDES CORPORATE UPDATE AND ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS Glocal Ruling from Arbitral Tribunal Regarding Glocal Yesterday, the Company provided an update on the arbitration brought by UpHealth Holdings, Inc. ("Holdings"), a wholly-owned direct subsidiary of UpHealth, against Glocal Healthcare Systems ("Glocal") and several of Glocal's officers and shareholders (together with Glocal, the "Respondents"). On March 18, 2024, the International Court of Arbi ...

FORM 10-Q ___________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 14000 S. Military Trail, Suite 203 Delray Beach, Florida 33484 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-38924 ...

For the transition period from ________ to ________ Commission File Number: 001-38924 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 UpHealth, Inc. FORM 10-Q ___________________________________ (Exact Name of Registrant as Specified in its Charter) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 193 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ___________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (888) 424-3646 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: For the transition period ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-04321 UpHealth, Inc. (Exact name of registrant as specified in its charter) Delaware 83-3838045 (State or ot ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ___________________________________ FORM 10-Q ___________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-38924 UpHealth, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 83-3838 ...